Rare diseases
Investigational molecules
Locations
Study of Roginolisib for Patients with Advanced Uveal Melanoma
ItalyStudy on Neoadjuvant Chemotherapy and Immunotherapy with Ipilimumab, Pemetrexed, and Drug Combination for Patients with Inoperable Pleural Mesothelioma
BelgiumStudy on Cabozantinib and Nivolumab for Older Patients with Kidney Cancer
FranceStudy Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer
AustriaStudy on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response
The NetherlandsStudy on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination
ItalyStudy on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment
FranceStudy of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma
The NetherlandsStudy on Cisplatin, Nab-paclitaxel, and Nivolumab with Radiotherapy for Patients with Non-Metastatic Muscle Invasive Bladder Cancer
ItalyStudy on CD8 PET Imaging for Patients with Metastatic Solid Tumors Using 89Zr-Df-crefmirlimab, Nivolumab, and Cetrelimab
The NetherlandsStudy on Pre-Operative Treatment for Breast Cancer Using Nivolumab, Ipilimumab, and Relatlimab for Patients with Breast Cancer
The NetherlandsStudy of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
